Index by author

01 March 2011; volume 37, issue 3

A

  1. Ackermann-Liebrich, U.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  2. Aggarwal, D.

    1. Aggarwal, D., P.R. Mohapatra, and P. Aggarwal. "Serum procalcitonin level: clinical significance." European Respiratory Journal 37.3 (2011): 723. Web. 26 Feb. 2020.

  3. Aggarwal, P.

    1. Aggarwal, D., P.R. Mohapatra, and P. Aggarwal. "Serum procalcitonin level: clinical significance." European Respiratory Journal 37.3 (2011): 723. Web. 26 Feb. 2020.

  4. Almonacid, L.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  5. Avol, E.L.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  6. Ayanoglu, G.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

B

  1. Barbé, F.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  2. Barceló, A.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  3. Barst, R.J.

    1. Barst, R.J. et al "Pulmonary arterial hypertension: a comparison between children and adults." European Respiratory Journal 37.3 (2011): 665-677. Web. 26 Feb. 2020.

  4. Bastain, T.M.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  5. Beghetti, M.

    1. Barst, R.J. et al "Pulmonary arterial hypertension: a comparison between children and adults." European Respiratory Journal 37.3 (2011): 665-677. Web. 26 Feb. 2020.

  6. Benveniste, O.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  7. Berhane, K.T.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  8. Berry, L.J.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  9. Bettschart, R.W.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  10. Bodini, A.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  11. Boeck, L.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  12. Boner, A.L.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.
    2. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  13. Bonilla, F.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  14. Bonsignore, M.R.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  15. Bridevaux, P-O.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  16. Brutsche, M.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  17. Bush, A.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.
    2. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  18. Buttacavoli, M.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

C

  1. Cangiotti, A.M.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  2. Caramella, D.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.

  3. Carnielli, V.P.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  4. Carroll, M.L.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  5. Cartin-Ceba, R.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  6. Catot, S.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  7. Cerri, S.

    1. Cerri, S., R.M. du Bois, and P. Spagnolo. "Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?." European Respiratory Journal 37.3 (2011): 489-491. Web. 26 Feb. 2020.

  8. Chinellato, I.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.

  9. Chouraki, B.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  10. Cogo, P.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  11. Cohen, J.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  12. Cole, T.J.

    1. Quanjer, P.H. et al "Influence of secular trends and sample size on reference equations for lung function tests." European Respiratory Journal 37.3 (2011): 658-664. Web. 26 Feb. 2020.

  13. Colomer, R.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  14. Conidi, M.E.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  15. Conti, G.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  16. Cooper, B.G.

    1. Steenbruggen, I. et al "Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe." European Respiratory Journal 37.3 (2011): 479-481. Web. 26 Feb. 2020.

  17. Cormier, Y.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Impaired function of regulatory T-cells in hypersensitivity pneumonitis." European Respiratory Journal 37.3 (2011): 632-639. Web. 26 Feb. 2020.

  18. Crapo, R.O.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  19. Curjuric, I.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

D

  1. Dalhoff, K.

    1. Witte, L. et al "Chlamydia pneumoniae is frequently detected in the blood after acute lung infection." European Respiratory Journal 37.3 (2011): 712-714. Web. 26 Feb. 2020.

  2. Dalphin, J-C.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  3. De Boer, A.H.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  4. de Castro, J.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  5. Delaval, P.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  6. De Luca, D.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  7. de Man, F.S.

    1. Handoko, M.L., F.S. de Man, and A. Vonk-Noordegraaf. "The rise and fall of endothelin receptor antagonists in congestive heart failure." European Respiratory Journal 37.3 (2011): 484-485. Web. 26 Feb. 2020.

  8. Desai, B.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  9. de Waal Malefyt, R.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  10. Diaz, R.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  11. Di Cicco, M.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.

  12. Domínguez, G.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  13. Don, M.

    1. Don, M.. "Risk factors of paediatric community-acquired pneumonia." European Respiratory Journal 37.3 (2011): 724-725. Web. 26 Feb. 2020.

  14. Donaldson, G.C.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

  15. Douma, W.R.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  16. Dratva, J.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  17. Droemann, D.

    1. Witte, L. et al "Chlamydia pneumoniae is frequently detected in the blood after acute lung infection." European Respiratory Journal 37.3 (2011): 712-714. Web. 26 Feb. 2020.

  18. du Bois, R.M.

    1. Cerri, S., R.M. du Bois, and P. Spagnolo. "Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?." European Respiratory Journal 37.3 (2011): 489-491. Web. 26 Feb. 2020.

  19. Dubucquoi, S.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  20. Dupuis, J.

    1. Jiang, B.H. et al "Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure." European Respiratory Journal 37.3 (2011): 578-586. Web. 26 Feb. 2020.

E

  1. Eggimann, P.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  2. Enright, P.L.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  3. Ertel, S.I.

    1. Barst, R.J. et al "Pulmonary arterial hypertension: a comparison between children and adults." European Respiratory Journal 37.3 (2011): 665-677. Web. 26 Feb. 2020.

  4. Esquinas, C.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  5. Ewig, S.

    1. Krüger, S., D. Frechen, and S. Ewig. "Prognosis of ventilator-associated pneumonia: what lies beneath." European Respiratory Journal 37.3 (2011): 486-488. Web. 26 Feb. 2020.

F

  1. Falaschetti, E.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  2. Feenstra, T.L.

    1. Hoogendoorn, M. et al "Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach." European Respiratory Journal 37.3 (2011): 508-515. Web. 26 Feb. 2020.

  3. Fick, R.B.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  4. Fischer, A.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  5. Flieger, A.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  6. Franke, A.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  7. Frechen, D.

    1. Krüger, S., D. Frechen, and S. Ewig. "Prognosis of ventilator-associated pneumonia: what lies beneath." European Respiratory Journal 37.3 (2011): 486-488. Web. 26 Feb. 2020.

  8. Frey, M.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

G

  1. Gaede, K.I.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  2. Gajic, O.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  3. Gangell, C.L.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  4. García, J.M.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  5. García, V.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  6. Garratt, L.W.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  7. Gerbase, M.W.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  8. Gilchrist, F.J.

    1. Lenney, W., and F.J. Gilchrist. "Pseudomonas aeruginosa and cyanide production." European Respiratory Journal 37.3 (2011): 482-483. Web. 26 Feb. 2020.

  9. Gilliland, F.D.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  10. Girard, M.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Impaired function of regulatory T-cells in hypersensitivity pneumonitis." European Respiratory Journal 37.3 (2011): 632-639. Web. 26 Feb. 2020.

  11. Goldring, J.J.P.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

  12. Grein, J.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  13. Grenouillet, F.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  14. Grigoryan, L.

    1. Verheij, T., J. Teepe, and L. Grigoryan. "From the authors:." European Respiratory Journal 37.3 (2011): 725. Web. 26 Feb. 2020.

  15. Guillem, V.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  16. Gúrpide, A.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

H

  1. Hachulla, E.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  2. Hall, G.L.

    1. Quanjer, P.H. et al "Influence of secular trends and sample size on reference equations for lung function tests." European Respiratory Journal 37.3 (2011): 658-664. Web. 26 Feb. 2020.

  3. Hamidou, M.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  4. Handoko, M.L.

    1. Handoko, M.L., F.S. de Man, and A. Vonk-Noordegraaf. "The rise and fall of endothelin receptor antagonists in congestive heart failure." European Respiratory Journal 37.3 (2011): 484-485. Web. 26 Feb. 2020.

  5. Herasevich, V.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  6. Herrera, M.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  7. Hervier, B.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  8. Hippenstiel, S.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  9. Hofmann, S.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  10. Hoogendoorn, M.

    1. Hoogendoorn, M. et al "Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach." European Respiratory Journal 37.3 (2011): 508-515. Web. 26 Feb. 2020.

  11. Hoogenveen, R.T.

    1. Hoogendoorn, M. et al "Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach." European Respiratory Journal 37.3 (2011): 508-515. Web. 26 Feb. 2020.

  12. Hurst, J.R.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

I

  1. Isla, D.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  2. Islam, T.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  3. Israël-Assayag, E.

    1. Girard, M., E. Israël-Assayag, and Y. Cormier. "Impaired function of regulatory T-cells in hypersensitivity pneumonitis." European Respiratory Journal 37.3 (2011): 632-639. Web. 26 Feb. 2020.

  4. Ivy, D.D.

    1. Barst, R.J. et al "Pulmonary arterial hypertension: a comparison between children and adults." European Respiratory Journal 37.3 (2011): 665-677. Web. 26 Feb. 2020.

J

  1. Jacobs, G.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  2. Jensen, R.L.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  3. Jiang, B.H.

    1. Jiang, B.H. et al "Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure." European Respiratory Journal 37.3 (2011): 578-586. Web. 26 Feb. 2020.

K

  1. Karatza, M.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  2. Kashyap, R.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  3. Knöpfli, B.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  4. Kojicic, M.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  5. Kopaka, M.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  6. Kor, D.J.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  7. Koutsourelakis, I.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  8. Krüger, S.

    1. Krüger, S., D. Frechen, and S. Ewig. "Prognosis of ventilator-associated pneumonia: what lies beneath." European Respiratory Journal 37.3 (2011): 486-488. Web. 26 Feb. 2020.

  9. Künzli, N.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

L

  1. Lange, C.

    1. Leung, C.C. et al "Treatment of latent infection with Mycobacterium tuberculosis: update 2010." European Respiratory Journal 37.3 (2011): 690-711. Web. 26 Feb. 2020.

  2. Lenney, W.

    1. Lenney, W., and F.J. Gilchrist. "Pseudomonas aeruginosa and cyanide production." European Respiratory Journal 37.3 (2011): 482-483. Web. 26 Feb. 2020.

  3. Leung, C.C.

    1. Leung, C.C. et al "Treatment of latent infection with Mycobacterium tuberculosis: update 2010." European Respiratory Journal 37.3 (2011): 690-711. Web. 26 Feb. 2020.

  4. Lianes, P.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  5. Linn, W.S.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  6. Lippmann, J.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  7. Lombardía, L.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  8. Lorenz, J.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  9. Lorthois, C.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

M

  1. Macchia, P.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.
    2. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  2. Maggi, F.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  3. Magkou, C.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  4. Malinchoc, M.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  5. Marrone, O.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  6. Marsch, S.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  7. Marthin, J.K.

    1. Marthin, J.K., and K.G. Nielsen. "Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 559-565. Web. 26 Feb. 2020.

  8. Massutí, B.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  9. Mattson, J.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  10. Mayo, C.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  11. McClanahan, T.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  12. McConnell, R.S.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  13. Michelucci, A.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  14. Miller, M.R.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  15. Millon, L.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  16. Mitchell, S.

    1. Steenbruggen, I. et al "Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe." European Respiratory Journal 37.3 (2011): 479-481. Web. 26 Feb. 2020.

  17. Miwa, S.

    1. Miwa, S.. "From the author:." European Respiratory Journal 37.3 (2011): 723. Web. 26 Feb. 2020.

  18. Mohapatra, P.R.

    1. Aggarwal, D., P.R. Mohapatra, and P. Aggarwal. "Serum procalcitonin level: clinical significance." European Respiratory Journal 37.3 (2011): 723. Web. 26 Feb. 2020.

  19. Müller-Quernheim, J.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  20. Musset, L.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

N

  1. N'Guessan, P.D.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  2. Nielsen, K.G.

    1. Marthin, J.K., and K.G. Nielsen. "Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 559-565. Web. 26 Feb. 2020.

  3. Nothnagel, M.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  4. Nunes, H.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

O

  1. Olmstead, S.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  2. Opitz, B.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

P

  1. Palange, P.

    1. Steenbruggen, I. et al "Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe." European Respiratory Journal 37.3 (2011): 479-481. Web. 26 Feb. 2020.

  2. Pargger, H.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  3. Paz-Ares, L.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  4. Pedersen, O.F.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  5. Peña, C.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  6. Perraki, E.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  7. Piastra, M.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  8. Pietrini, D.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  9. Pifferi, M.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.
    2. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  10. Pollok, I.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  11. Polo, E.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  12. Pons, M.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  13. Porta, R.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  14. Postma, D.S.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  15. Pradas, A.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  16. Provencio, M.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  17. Puig, T.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

Q

  1. Quanjer, P.H.

    1. Quanjer, P.H. et al "Influence of secular trends and sample size on reference equations for lung function tests." European Respiratory Journal 37.3 (2011): 658-664. Web. 26 Feb. 2020.
    2. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  2. Queralt, C.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  3. Quint, J.K.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

R

  1. Rakic, J.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  2. Rappaport, E.B.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  3. Reboux, G.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  4. Reece, S.P.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  5. Reguart, N.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  6. Ricci, V.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  7. Rieder, H.L.

    1. Leung, C.C. et al "Treatment of latent infection with Mycobacterium tuberculosis: update 2010." European Respiratory Journal 37.3 (2011): 690-711. Web. 26 Feb. 2020.

  8. Rochat, T.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  9. Rosell, R.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  10. Rosenstiel, P.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  11. Roussel, S.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  12. Roussos, C.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  13. Rupp, J.

    1. Witte, L. et al "Chlamydia pneumoniae is frequently detected in the blood after acute lung infection." European Respiratory Journal 37.3 (2011): 712-714. Web. 26 Feb. 2020.

  14. Ruppel, G.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  15. Rutten-van Mölken, M.P.

    1. Hoogendoorn, M. et al "Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach." European Respiratory Journal 37.3 (2011): 508-515. Web. 26 Feb. 2020.

S

  1. Saadati, H.R.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  2. Salam, M.T.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  3. Salinas, P.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  4. Sánchez-Torres, J.M.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  5. Scharf, S.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  6. Schindler, C.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  7. Schmeck, B.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  8. Schouten, J.P.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  9. Schreiber, S.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  10. Schürmann, M.

    1. Fischer, A. et al "Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes." European Respiratory Journal 37.3 (2011): 610-616. Web. 26 Feb. 2020.

  11. Schwartz, J.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  12. Seemungal, T.R.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

  13. Severin, T.

    1. Steenbruggen, I. et al "Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe." European Respiratory Journal 37.3 (2011): 479-481. Web. 26 Feb. 2020.

  14. Sheil, B.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  15. Shi, Y.

    1. Jiang, B.H. et al "Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure." European Respiratory Journal 37.3 (2011): 578-586. Web. 26 Feb. 2020.

  16. Siegemund, M.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  17. Silva, J.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  18. Simi, P.

    1. Pifferi, M. et al "Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 572-577. Web. 26 Feb. 2020.

  19. Sly, P.D.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  20. Smith, D.J.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  21. Smyrnios, N.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  22. Spagnolo, P.

    1. Cerri, S., R.M. du Bois, and P. Spagnolo. "Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?." European Respiratory Journal 37.3 (2011): 489-491. Web. 26 Feb. 2020.

  23. Stanojevic, S.

    1. Quanjer, P.H. et al "Influence of secular trends and sample size on reference equations for lung function tests." European Respiratory Journal 37.3 (2011): 658-664. Web. 26 Feb. 2020.

  24. Steenbruggen, I.

    1. Steenbruggen, I. et al "Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe." European Respiratory Journal 37.3 (2011): 479-481. Web. 26 Feb. 2020.

  25. Steiropoulos, P.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.

  26. Stocks, J.

    1. Quanjer, P.H. et al "Influence of secular trends and sample size on reference equations for lung function tests." European Respiratory Journal 37.3 (2011): 658-664. Web. 26 Feb. 2020.
    2. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

  27. Stolz, D.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  28. Stutz, M.D.

    1. Stutz, M.D. et al "Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis." European Respiratory Journal 37.3 (2011): 553-558. Web. 26 Feb. 2020.

  29. Suttorp, N.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  30. Swanney, M.P.

    1. Quanjer, P.H. et al "The need to change the method for defining mild airway obstruction." European Respiratory Journal 37.3 (2011): 720-722. Web. 26 Feb. 2020.

T

  1. Tamm, M.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  2. Tardif, J-C.

    1. Jiang, B.H. et al "Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure." European Respiratory Journal 37.3 (2011): 578-586. Web. 26 Feb. 2020.

  3. Tarón, M.

    1. Porta, R. et al "Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation." European Respiratory Journal 37.3 (2011): 624-631. Web. 26 Feb. 2020.

  4. Teepe, J.

    1. Verheij, T., J. Teepe, and L. Grigoryan. "From the authors:." European Respiratory Journal 37.3 (2011): 725. Web. 26 Feb. 2020.

  5. ten Hacken, N.H.T.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  6. Thakkar, N.

    1. Boeck, L. et al "Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP." European Respiratory Journal 37.3 (2011): 595-603. Web. 26 Feb. 2020.

  7. Thakur, L.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  8. Thakur, S.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

  9. Thomas, R.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  10. Tillie-Leblond, I.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.

  11. Towers, M.A.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  12. Tridente, A.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  13. Trillo-Alvarez, C.

    1. Trillo-Alvarez, C. et al "Acute lung injury prediction score: derivation and validation in a population-based sample." European Respiratory Journal 37.3 (2011): 604-609. Web. 26 Feb. 2020.

U

  1. Upham, J.W.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  2. Uzunhan, Y.

    1. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

V

  1. Vagiakis, E.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  2. Van Scott, M.R.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  3. Varela, A.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  4. Verheij, T.

    1. Verheij, T., J. Teepe, and L. Grigoryan. "From the authors:." European Respiratory Journal 37.3 (2011): 725. Web. 26 Feb. 2020.

  5. Vestbo, J.

    1. Hoogendoorn, M. et al "Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach." European Respiratory Journal 37.3 (2011): 508-515. Web. 26 Feb. 2020.

  6. Vonk, J.M.

    1. Cohen, J. et al "Particle size matters: diagnostics and treatment of small airways involvement in asthma." European Respiratory Journal 37.3 (2011): 532-540. Web. 26 Feb. 2020.

  7. Vonk-Noordegraaf, A.

    1. Handoko, M.L., F.S. de Man, and A. Vonk-Noordegraaf. "The rise and fall of endothelin receptor antagonists in congestive heart failure." European Respiratory Journal 37.3 (2011): 484-485. Web. 26 Feb. 2020.

W

  1. Wallaert, B.

    1. Tillie-Leblond, I. et al "Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria." European Respiratory Journal 37.3 (2011): 640-647. Web. 26 Feb. 2020.
    2. Hervier, B. et al "Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies." European Respiratory Journal 37.3 (2011): 714-717. Web. 26 Feb. 2020.

  2. Wardle, R.L.

    1. Ayanoglu, G. et al "Modelling asthma in macaques: longitudinal changes in cellular and molecular markers." European Respiratory Journal 37.3 (2011): 541-552. Web. 26 Feb. 2020.

  3. Wedzicha, J.A.

    1. Quint, J.K. et al "Predictive accuracy of patient-reported exacerbation frequency in COPD." European Respiratory Journal 37.3 (2011): 501-507. Web. 26 Feb. 2020.

  4. Witte, L.

    1. Witte, L. et al "Chlamydia pneumoniae is frequently detected in the blood after acute lung infection." European Respiratory Journal 37.3 (2011): 712-714. Web. 26 Feb. 2020.

Y

  1. Yerkovich, S.T.

    1. Smith, D.J. et al "Reduced soluble receptor for advanced glycation end-products in COPD." European Respiratory Journal 37.3 (2011): 516-522. Web. 26 Feb. 2020.

  2. Yew, W.W.

    1. Leung, C.C. et al "Treatment of latent infection with Mycobacterium tuberculosis: update 2010." European Respiratory Journal 37.3 (2011): 690-711. Web. 26 Feb. 2020.

Z

  1. Zaballos, Á.

    1. Silva, J. et al "Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival." European Respiratory Journal 37.3 (2011): 617-623. Web. 26 Feb. 2020.

  2. Zahlten, J.

    1. Lorenz, J. et al "Legionella pneumophila-induced IκBζ-dependent expression of interleukin-6 in lung epithelium." European Respiratory Journal 37.3 (2011): 648-657. Web. 26 Feb. 2020.

  3. Zakynthinos, S.

    1. Koutsourelakis, I. et al "Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification." European Respiratory Journal 37.3 (2011): 587-594. Web. 26 Feb. 2020.

  4. Zangani, M.

    1. Pifferi, M. et al "Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia." European Respiratory Journal 37.3 (2011): 566-571. Web. 26 Feb. 2020.

  5. Zecca, E.

    1. De Luca, D. et al "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review." European Respiratory Journal 37.3 (2011): 678-689. Web. 26 Feb. 2020.

  6. Zemp, E.

    1. Curjuric, I. et al "Determinants of change in airway reactivity over 11 years in the SAPALDIA population study." European Respiratory Journal 37.3 (2011): 492-500. Web. 26 Feb. 2020.

  7. Zhang, Y.

    1. Bastain, T.M. et al "Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study." European Respiratory Journal 37.3 (2011): 523-531. Web. 26 Feb. 2020.

  8. Zito, A.

    1. Zito, A. et al "Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries." European Respiratory Journal 37.3 (2011): 717-719. Web. 26 Feb. 2020.
Back to top
European Respiratory Journal: 37 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts